The San Diego firm took a step in that direction on Tuesday, when it unveiled what it says will be the world’s largest ...
Under an alliance framework with AstraZeneca, Merck, and Eli Lilly and Company leading as founding participants, the Atlas is ...
Illumina unveiled the Billion Cell Atlas, a large‑scale genetic perturbation dataset built with pharma partners to advance AI‑powered drug discovery, target validation, and disease biology.
Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
PHILADELPHIA, Nov. 12, 2025 /PRNewswire/ -- Cell Surface Bio (CSB) announces the launch VeRSa-Select™, a custom antibody service providing scientists with unparalleled access to the highest quality ...
Oversubscribed GBP2.5M seed round led by Ahren Innovation Capital -- Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--January 12, 2026-- ...
Explore the groundbreaking AI genomics platform, Inference, launched by Variant Bio to enhance drug discovery using genetic ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
Proteasomes are molecular machines for breaking down proteins. Drugmakers are working to coopt this process with targeted therapies. This story was originally published on BioPharma Dive. To receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback